Search - Prime Therapeutics

411 Results for GLP-1 Pipeline Update

Star Tribune: Most patients quit GLP-1 drugs in two years, jeopardizing their weight loss

Star Tribune

PA Sub-Categories: GLP-1 Prime Article: In the News
Managing the mad rush on GLP-1s: How to prioritize patients who have on-label prescriptions for diabetes therapy

Shortages in the manufacturing chain have led to label hopping and an increase in off-label use

PA Sub-Categories: GLP-1 Prime Article: Perspectives
A new era in liver health: How GLP-1s are a MASH treatment breakthrough

In the latest episode of the “Pharmacy Friends” podcast, hear about a new clinical report from Prime Therapeutics that dives into the latest evidence-based insights related to the rising prevalence...

PA Sub-Categories: GLP-1 Prime Article: Stories
Ground yourself in the basics about biosimilar drugs, Part 1

Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.

PA Sub-Categories: Specialty drugs Prime Article: Perspectives